Literature DB >> 11550824

Identification and quantitation of 11-nor-delta9-tetrahydrocannabivarin-9-carboxylic acid, a major metabolite of delta9-tetrahydrocannabivarin.

M A ElSohly1, S Feng, T P Murphy, A W Warrington, S Ross, A Nimrod, Z Mehmedic, N Fortner.   

Abstract

After incubation of delta9-tetrahydrocannabivarin with human hepatocytes, a major metabolic product was detected by gas chromatography-mass spectrometry that showed identical retention time and mass spectrum to the synthetic 11-nor-delta9-tetrahydrocannabivarin-9-carboxylic acid (11-nor-delta9-THCV-9-COOH). Analysis of human urine specimens from marijuana users and plasma samples from Marinol users showed that 11-nor-delta9-THCV-9-COOH was only present in urine specimens of marijuana users. These results supported the conclusion that identification of 11-nor-delta9-THCV-9-COOH in a donor's urine specimen indicates the use or ingestion of cannabis-related product(s) and would not explain the sole use of Marinol.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11550824     DOI: 10.1093/jat/25.6.476

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  2 in total

1.  Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.

Authors:  Madeleine J Swortwood; Matthew N Newmeyer; Maria Andersson; Osama A Abulseoud; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2016-10-13       Impact factor: 3.345

2.  Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol.

Authors:  Frances R Levin; John J Mariani; Daniel J Brooks; Shan Xie; Kathleen A Murray
Journal:  Drug Alcohol Depend       Date:  2009-09-03       Impact factor: 4.492

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.